Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Conformis Inc CS (CFMS)

Conformis Inc CS (CFMS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 142,166
  • Shares Outstanding, K 68,679
  • Annual Sales, $ 89,790 K
  • Annual Income, $ -43,370 K
  • 60-Month Beta 2.28
  • Price/Sales 1.43
  • Price/Cash Flow N/A
  • Price/Book 4.55

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.11
  • Number of Estimates 2
  • High Estimate -0.09
  • Low Estimate -0.12
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +8.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.41 +46.81%
on 08/05/19
3.11 -33.33%
on 07/22/19
-1.01 (-32.79%)
since 07/19/19
3-Month
1.41 +46.81%
on 08/05/19
4.83 -57.14%
on 06/11/19
-1.35 (-39.47%)
since 05/17/19
52-Week
0.36 +475.00%
on 12/31/18
4.83 -57.14%
on 06/11/19
+1.16 (+127.47%)
since 08/17/18

Most Recent Stories

More News
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Conformis, Inc. (CFMS)

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Conformis, Inc. ("Conformis" or the Company") (NASDAQ: CFMS). Investors are encouraged...

CFMS : 2.07 (+10.70%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Conformis, Inc. - CFMS

Pomerantz LLP is investigating claims on behalf of investors of Conformis, Inc. ("Conformis" or the "Company") (NASDAQ: CFMS). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com...

CFMS : 2.07 (+10.70%)
ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates

ConforMIS (CFMS) delivered earnings and revenue surprises of 0.00% and 1.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

CFMS : 2.07 (+10.70%)
Conformis Reports Second Quarter 2019 Financial Results and Updates Product Revenue Expectations

Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants...

CFMS : 2.07 (+10.70%)
Conformis Establishes Alliance to Focus on ASC Joint Replacement

Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants...

CFMS : 2.07 (+10.70%)
Conformis to Host Second Quarter 2019 Financial Results Webcast on July 31, 2019

Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, July 31, 2019, at 4:30 p.m. Eastern Time to discuss its financial results for the second quarter ended June 30,...

CFMS : 2.07 (+10.70%)
Hottest Wall Street Stories of First Half

We discuss some of the events that dominated the headlines in the first half and influenced the market.

AT : 2.35 (+0.86%)
AGI : 6.97 (-0.43%)
AU : 20.28 (-3.61%)
TRCH : 1.40 (+3.32%)
CLPR : 11.04 (+0.18%)
INVH : 28.58 (+0.92%)
CFMS : 2.07 (+10.70%)
BEP : 36.90 (+1.68%)
PES : 0.16 (-5.36%)
Conformis Secures Up to $30 Million in Debt Financing and $3 Million in Equity Financing from Innovatus Life Sciences and East West Bank

Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants...

EWBC : 39.91 (unch)
CFMS : 2.07 (+10.70%)
ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates

ConforMIS (CFMS) delivered earnings and revenue surprises of 0.00% and 2.64%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

CFMS : 2.07 (+10.70%)
Conformis Reports First Quarter 2019 Financial Results

Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants...

CFMS : 2.07 (+10.70%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Bearish.

See More Share

Trade CFMS with:

Business Summary

ConforMIS, Inc. is a medical technology company which develops, manufacture and sells joint replacement implants. The Company's iFit technology platform consists of iFit Design, iFit Printing and iFit Just-in-Time Delivery. It operates primarily in the United States, Germany and the United Kingdom. The...

See More

Key Turning Points

2nd Resistance Point 2.36
1st Resistance Point 2.22
Last Price 2.07
1st Support Level 1.90
2nd Support Level 1.72

See More

52-Week High 4.83
Fibonacci 61.8% 3.12
Fibonacci 50% 2.60
Fibonacci 38.2% 2.07
Last Price 2.07
52-Week Low 0.36

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar